Is it now the time to update treatment protocols for lymphomas with new anti-virus systems?

Leukemia. 2004 Oct;18(10):1572-5. doi: 10.1038/sj.leu.2403447.
No abstract available

Publication types

  • Comment
  • Editorial

MeSH terms

  • Antiviral Agents / therapeutic use*
  • Drug Therapy, Combination
  • Hepacivirus / genetics
  • Hepacivirus / isolation & purification
  • Hepacivirus / pathogenicity*
  • Hepatitis C / complications
  • Hepatitis C / drug therapy*
  • Hepatitis C / virology
  • Humans
  • Interferon-alpha / therapeutic use
  • Lymphoma, B-Cell / complications
  • Lymphoma, B-Cell / drug therapy
  • Lymphoma, B-Cell / virology*
  • Ribavirin / therapeutic use
  • Treatment Outcome

Substances

  • Antiviral Agents
  • Interferon-alpha
  • Ribavirin